➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Johnson and Johnson
Colorcon
Baxter
AstraZeneca
Express Scripts

Last Updated: September 28, 2021

DrugPatentWatch Database Preview

Epinephrine; lidocaine hydrochloride - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

What are the generic sources for epinephrine; lidocaine hydrochloride and what is the scope of patent protection?

Epinephrine; lidocaine hydrochloride is the generic ingredient in nine branded drugs marketed by Carlisle, Belmora Llc, Eastman Kodak, Hospira, West-ward Pharms Int, Abbott, Bel Mar, Dell Labs, Intl Medication, Watson Labs, Pharmaton, Septodont, Dentsply Pharm, Astrazeneca, Fresenius Kabi Usa, Vyteris, Iomed, and Empi, and is included in thirty-one NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Epinephrine; lidocaine hydrochloride has eight patent family members in seven countries.

There are twenty-one drug master file entries for epinephrine; lidocaine hydrochloride. Ten suppliers are listed for this compound.

Summary for epinephrine; lidocaine hydrochloride
International Patents:8
US Patents:1
Tradenames:9
Applicants:18
NDAs:31
Drug Master File Entries: 21
Finished Product Suppliers / Packagers: 10
Clinical Trials: 177
DailyMed Link:epinephrine; lidocaine hydrochloride at DailyMed
Recent Clinical Trials for epinephrine; lidocaine hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of ChilePhase 4
Loma Linda UniversityPhase 4
Bozyaka Training and Research HospitalPhase 4

See all epinephrine; lidocaine hydrochloride clinical trials

Anatomical Therapeutic Chemical (ATC) Classes for epinephrine; lidocaine hydrochloride
A01AD Other agents for local oral treatment
A01A STOMATOLOGICAL PREPARATIONS
A01 STOMATOLOGICAL PREPARATIONS
A Alimentary tract and metabolism
B02BC Local hemostatics
B02B VITAMIN K AND OTHER HEMOSTATICS
B02 ANTIHEMORRHAGICS
B Blood and blood forming organs
C01BB Antiarrhythmics, class Ib
C01B ANTIARRHYTHMICS, CLASS I AND III
C01 CARDIAC THERAPY
C Cardiovascular system
C01CA Adrenergic and dopaminergic agents
C01C CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
C01 CARDIAC THERAPY
C Cardiovascular system
C05AD Local anesthetics
C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE
C05 VASOPROTECTIVES
C Cardiovascular system
D04AB Anesthetics for topical use
D04A ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.
D04 ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.
D Dermatologicals
N01BB Amides
N01B ANESTHETICS, LOCAL
N01 ANESTHETICS
N Nervous system
R01AA Sympathomimetics, plain
R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE
R01 NASAL PREPARATIONS
R Respiratory system
R02AD Anesthetics, local
R02A THROAT PREPARATIONS
R02 THROAT PREPARATIONS
R Respiratory system
R03AA Alpha- and beta-adrenoreceptor agonists
R03A ADRENERGICS, INHALANTS
R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R Respiratory system
S01EA Sympathomimetics in glaucoma therapy
S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS
S01 OPHTHALMOLOGICALS
S Sensory organs
S01HA Local anesthetics
S01H LOCAL ANESTHETICS
S01 OPHTHALMOLOGICALS
S Sensory organs
S02DA Analgesics and anesthetics
S02D OTHER OTOLOGICALS
S02 OTOLOGICALS
S Sensory organs

US Patents and Regulatory Information for epinephrine; lidocaine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmaton LIDOCATON epinephrine; lidocaine hydrochloride INJECTABLE;INJECTION 084729-001 Aug 17, 1983 DISCN No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Dentsply Pharm XYLOCAINE DENTAL WITH EPINEPHRINE epinephrine; lidocaine hydrochloride INJECTABLE;INJECTION 021381-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Hospira LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE epinephrine; lidocaine hydrochloride INJECTABLE;INJECTION 089644-001 Jun 21, 1988 AP RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Astrazeneca XYLOCAINE W/ EPINEPHRINE epinephrine; lidocaine hydrochloride INJECTABLE;INJECTION 010418-006 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
West-ward Pharms Int LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE epinephrine; lidocaine hydrochloride INJECTABLE;INJECTION 080406-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for epinephrine; lidocaine hydrochloride

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Johnson and Johnson
Colorcon
Baxter
AstraZeneca
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.